vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and SPS COMMERCE INC (SPSC). Click either name above to swap in a different company.

ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($284.0M vs $192.7M, roughly 1.5× SPS COMMERCE INC). ACADIA PHARMACEUTICALS INC runs the higher net margin — 96.3% vs 13.4%, a 82.9% gap on every dollar of revenue. On growth, SPS COMMERCE INC posted the faster year-over-year revenue change (12.7% vs 9.4%). Over the past eight quarters, ACADIA PHARMACEUTICALS INC's revenue compounded faster (17.5% CAGR vs 13.5%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

SPS Commerce, Inc. is a technology and application software company based in the United States that provides cloud-based supply chain management software. The company's headquarters are located in Minneapolis, Minnesota, but it also has a US office in New Jersey, and international locations in Amsterdam, Beijing, Breukelen, Hong Kong, Kyiv, Melbourne, Montpellier, Sydney, and Toronto.

ACAD vs SPSC — Head-to-Head

Bigger by revenue
ACAD
ACAD
1.5× larger
ACAD
$284.0M
$192.7M
SPSC
Growing faster (revenue YoY)
SPSC
SPSC
+3.3% gap
SPSC
12.7%
9.4%
ACAD
Higher net margin
ACAD
ACAD
82.9% more per $
ACAD
96.3%
13.4%
SPSC
Faster 2-yr revenue CAGR
ACAD
ACAD
Annualised
ACAD
17.5%
13.5%
SPSC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ACAD
ACAD
SPSC
SPSC
Revenue
$284.0M
$192.7M
Net Profit
$273.6M
$25.8M
Gross Margin
90.8%
70.4%
Operating Margin
6.1%
18.0%
Net Margin
96.3%
13.4%
Revenue YoY
9.4%
12.7%
Net Profit YoY
90.3%
47.2%
EPS (diluted)
$1.61
$0.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
SPSC
SPSC
Q4 25
$284.0M
$192.7M
Q3 25
$278.6M
$189.9M
Q2 25
$264.6M
$187.4M
Q1 25
$244.3M
$181.5M
Q4 24
$259.6M
$170.9M
Q3 24
$250.4M
$163.7M
Q2 24
$242.0M
$153.6M
Q1 24
$205.8M
$149.6M
Net Profit
ACAD
ACAD
SPSC
SPSC
Q4 25
$273.6M
$25.8M
Q3 25
$71.8M
$25.6M
Q2 25
$26.7M
$19.7M
Q1 25
$19.0M
$22.2M
Q4 24
$143.7M
$17.6M
Q3 24
$32.8M
$23.5M
Q2 24
$33.4M
$18.0M
Q1 24
$16.6M
$18.0M
Gross Margin
ACAD
ACAD
SPSC
SPSC
Q4 25
90.8%
70.4%
Q3 25
92.2%
69.5%
Q2 25
92.2%
68.1%
Q1 25
91.7%
68.7%
Q4 24
91.6%
67.5%
Q3 24
92.5%
68.5%
Q2 24
92.5%
66.1%
Q1 24
88.8%
65.6%
Operating Margin
ACAD
ACAD
SPSC
SPSC
Q4 25
6.1%
18.0%
Q3 25
12.8%
16.4%
Q2 25
12.2%
14.1%
Q1 25
7.9%
14.3%
Q4 24
59.1%
14.5%
Q3 24
12.6%
15.6%
Q2 24
12.6%
15.1%
Q1 24
7.4%
10.3%
Net Margin
ACAD
ACAD
SPSC
SPSC
Q4 25
96.3%
13.4%
Q3 25
25.8%
13.5%
Q2 25
10.1%
10.5%
Q1 25
7.8%
12.2%
Q4 24
55.4%
10.3%
Q3 24
13.1%
14.3%
Q2 24
13.8%
11.7%
Q1 24
8.0%
12.0%
EPS (diluted)
ACAD
ACAD
SPSC
SPSC
Q4 25
$1.61
$0.69
Q3 25
$0.42
$0.67
Q2 25
$0.16
$0.52
Q1 25
$0.11
$0.58
Q4 24
$0.86
$0.46
Q3 24
$0.20
$0.62
Q2 24
$0.20
$0.48
Q1 24
$0.10
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
SPSC
SPSC
Cash + ST InvestmentsLiquidity on hand
$177.7M
$151.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.2B
$973.9M
Total Assets
$1.6B
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
SPSC
SPSC
Q4 25
$177.7M
$151.4M
Q3 25
$258.0M
$133.7M
Q2 25
$253.6M
$107.6M
Q1 25
$217.7M
$94.9M
Q4 24
$319.6M
$241.0M
Q3 24
$155.1M
$205.8M
Q2 24
$177.1M
$271.8M
Q1 24
$204.7M
$290.8M
Stockholders' Equity
ACAD
ACAD
SPSC
SPSC
Q4 25
$1.2B
$973.9M
Q3 25
$917.3M
$958.9M
Q2 25
$822.4M
$949.8M
Q1 25
$765.2M
$920.9M
Q4 24
$732.8M
$854.7M
Q3 24
$577.2M
$829.4M
Q2 24
$516.7M
$703.4M
Q1 24
$464.0M
$683.0M
Total Assets
ACAD
ACAD
SPSC
SPSC
Q4 25
$1.6B
$1.2B
Q3 25
$1.3B
$1.2B
Q2 25
$1.2B
$1.1B
Q1 25
$1.1B
$1.1B
Q4 24
$1.2B
$1.0B
Q3 24
$976.9M
$1.0B
Q2 24
$914.1M
$854.5M
Q1 24
$855.1M
$839.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
SPSC
SPSC
Operating Cash FlowLast quarter
$-48.7M
$45.9M
Free Cash FlowOCF − Capex
$38.2M
FCF MarginFCF / Revenue
19.8%
Capex IntensityCapex / Revenue
4.0%
Cash ConversionOCF / Net Profit
-0.18×
1.78×
TTM Free Cash FlowTrailing 4 quarters
$152.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
SPSC
SPSC
Q4 25
$-48.7M
$45.9M
Q3 25
$74.3M
$60.6M
Q2 25
$64.0M
$32.3M
Q1 25
$20.3M
$40.0M
Q4 24
$40.4M
$40.6M
Q3 24
$63.2M
$53.3M
Q2 24
$25.0M
$29.4M
Q1 24
$29.1M
$34.1M
Free Cash Flow
ACAD
ACAD
SPSC
SPSC
Q4 25
$38.2M
Q3 25
$73.9M
$54.6M
Q2 25
$25.7M
Q1 25
$33.8M
Q4 24
$34.3M
Q3 24
$63.2M
$48.1M
Q2 24
$24.4M
Q1 24
$30.5M
FCF Margin
ACAD
ACAD
SPSC
SPSC
Q4 25
19.8%
Q3 25
26.5%
28.7%
Q2 25
13.7%
Q1 25
18.6%
Q4 24
20.1%
Q3 24
25.2%
29.4%
Q2 24
15.9%
Q1 24
20.4%
Capex Intensity
ACAD
ACAD
SPSC
SPSC
Q4 25
4.0%
Q3 25
0.1%
3.2%
Q2 25
3.6%
Q1 25
3.4%
Q4 24
3.6%
Q3 24
0.0%
3.2%
Q2 24
3.3%
Q1 24
2.4%
Cash Conversion
ACAD
ACAD
SPSC
SPSC
Q4 25
-0.18×
1.78×
Q3 25
1.03×
2.37×
Q2 25
2.40×
1.64×
Q1 25
1.07×
1.80×
Q4 24
0.28×
2.31×
Q3 24
1.93×
2.27×
Q2 24
0.75×
1.63×
Q1 24
1.76×
1.89×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACAD
ACAD

Nuplazid$174.4M61%
Daybue$109.6M39%

SPSC
SPSC

Recurring Revenues$184.5M96%
One Time Revenues$8.1M4%
Set Up Fees$4.1M2%

Related Comparisons